Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hoft

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Missouri Medicine|September 13, 2014
Development of vaccines to control the worldwide tuberculosis pandemicDaniel F Hoft
Lancet (London, England)|July 16, 2008
Tuberculosis vaccine development: goals, immunological design, and evaluationDaniel F Hoft
Missouri Medicine|September 13, 2014
Research continues on new vaccines and biologics at the Saint Louis University Center for Vaccine DevelopmentDaniel F Hoft
Immunotargets and Therapy|August 17, 2016
Immunotherapy for tuberculosis: future prospectsGetahun Abate, Daniel F Hoft
European Urology|July 3, 2014
Variations between bacillus Calmette-Guérin strains: lessons from tuberculosis preventionGetahun Abate, Daniel F Hoft
Missouri Medicine|September 13, 2014
Progress toward the development of universal influenza vaccinesDaniel F Hoft, Robert B Belshe
The New England Journal of Medicine|December 14, 2004
The genetic archaeology of influenzaDaniel F Hoft, Robert B Belshe
Infection and Immunity|July 26, 2005
Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogenDaniel F Hoft, Chris S Eickhoff
The Journal of Clinical Investigation|March 3, 2020
Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapyXia Liu, Daniel F Hoft, Guangyong Peng
Trends in Immunology|January 2, 2022
Tumor microenvironment metabolites directing T cell differentiation and functionXia Liu, Daniel F Hoft, Guangyong Peng
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Missouri Medicine|September 13, 2014
Development of vaccines to control the worldwide tuberculosis pandemicDaniel F Hoft
Lancet (London, England)|July 16, 2008
Tuberculosis vaccine development: goals, immunological design, and evaluationDaniel F Hoft
Missouri Medicine|September 13, 2014
Research continues on new vaccines and biologics at the Saint Louis University Center for Vaccine DevelopmentDaniel F Hoft
Immunotargets and Therapy|August 17, 2016
Immunotherapy for tuberculosis: future prospectsGetahun Abate, Daniel F Hoft
European Urology|July 3, 2014
Variations between bacillus Calmette-Guérin strains: lessons from tuberculosis preventionGetahun Abate, Daniel F Hoft
Missouri Medicine|September 13, 2014
Progress toward the development of universal influenza vaccinesDaniel F Hoft, Robert B Belshe
The New England Journal of Medicine|December 14, 2004
The genetic archaeology of influenzaDaniel F Hoft, Robert B Belshe
Infection and Immunity|July 26, 2005
Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogenDaniel F Hoft, Chris S Eickhoff
The Journal of Clinical Investigation|March 3, 2020
Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapyXia Liu, Daniel F Hoft, Guangyong Peng
Trends in Immunology|January 2, 2022
Tumor microenvironment metabolites directing T cell differentiation and functionXia Liu, Daniel F Hoft, Guangyong Peng
Pageof 13